Clinical Trials List
2019-07-01 - 2023-05-31
Phase II
Terminated3
ICD-10C50.911
Malignant neoplasm of unspecified site of right female breast
ICD-10C50.912
Malignant neoplasm of unspecified site of left female breast
ICD-10C50.919
Malignant neoplasm of unspecified site of unspecified female breast
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9174.9
Malignant neoplasm of female breast, unspecified
-
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- 張端瑩
- 羅喬
- Wei-Wu Chen
- 陳怡君
- 陳怡君
- 林季宏 未分科
- MING-YANG WANG
The Actual Total Number of Participants Enrolled
0 Completed
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
379 participants
